What it's for (Indications)
- Fluphenazine + Nortriptyline combination therapy is indicated for the management of specific psychiatric conditions, primarily moderate to severe depressive states that are accompanied by significant anxiety, agitation, or specific psychotic features.
- This combination is particularly suited for patients where single-agent antidepressant therapy has been inadequate or where the symptom profile necessitates the dual action of an antidepressant and a low-dose antipsychotic.
- The nortriptyline component targets the core depressive symptoms such as low mood, anhedonia, and vegetative symptoms, while the fluphenazine component addresses associated anxiety, tension, psychomotor agitation, and any co-occurring delusional thoughts, hallucinations, or thought disorganization that may manifest within a depressive episode.
- It is important to note that this combination is typically reserved for cases where the comprehensive symptomatic picture aligns with the therapeutic spectrum of both compounds, offering a synergistic approach to complex mood and thought disturbances, and is not generally considered a first-line treatment for uncomplicated depression.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Specific dosage guidelines are not provided in the local Pakistani or US FDA data. Dosage for fluphenazine and nortriptyline, when used as a combination, must be individualized based on the patient's clinical response, tolerance, and severity of symptoms, typically starting with low doses and titrating upwards. Regular monitoring is essential. |
Safety & Warnings
Common Side Effects
- Decreased WBCs, increased prolactin hormones, abnormality of muscle tone, abnormality of voluntary movements, restlessness, Parkinsonism, drowsiness, insomnia, agitation, increased heart rate, arrhythmia, decreased blood pressure, dry mouth, blurred vision, respiratory depression, nasal stuffiness, rash, photosensitivity, increased blood glucose, impaired temperature regulation, and male sexual dysfunction.
Serious Warnings
- Black Box Warning: None
- Use with caution in pregnancy (risk cannot be ruled out; consult physician), and during lactation (caution advised; consult physician).
- Avoid driving or operating machinery as this drug may affect ability.
- Avoid alcohol consumption.
- Caution is advised in patients with liver disease, respiratory disease, cardiac disease, cardiac arrhythmias, thyrotoxicosis (increased thyroid hormones), epilepsy, glaucoma, hypothyroidism (decreased thyroid hormones), Myasthenia Gravis, and prostatic hypertrophy.
- This drug should also be used with caution in Parkinson's disease, during very hot weather, and in the elderly.
- Gradual withdrawal of this drug is advisable.
How it Works (Mechanism of Action)
Mechanism of action for the combination of fluphenazine (a phenothiazine antipsychotic) and nortriptyline (a tricyclic antidepressant) involves their individual pharmacological effects. Fluphenazine is thought to exert its antipsychotic effects by blocking postsynaptic dopamine D2 receptors in the mesolimbic pathway of the brain. Nortriptyline primarily inhibits the reuptake of norepinephrine and serotonin at presynaptic neuronal membranes, thereby increasing their concentrations in the synaptic cleft, which contributes to its antidepressant and anxiolytic effects.
Commercial Brands (Alternatives)
No other brands found for this formula.